721 results
8-K
EX-99.1
TEVA
Teva- Pharmaceutical Industries Ltd.
8 May 24
Teva Reports First Quarter 2024 Financial Results and Reaffirms 2024 Financial Outlook
7:01am
first quarter 2024 results and overall business environment. A question & answer session will follow.
In order to participate, please register
DEFA14A
TEVA
Teva- Pharmaceutical Industries Ltd.
16 Apr 24
Additional proxy soliciting materials
4:16pm
screen for your delivery preferences. Step 5: Vote your shares. When you go online, you can also help the environment by consenting to receive
8-K
EX-99.1
npoce8k1aygi
31 Jan 24
Results of Operations and Financial Condition
7:00am
8-K
EX-99.1
xc96ex cnulw
8 Nov 23
2023 revenues outlook revised to $15.1 - $15.5 billion from $15.0 - $15.4 billion
7:01am
8-K
EX-99.1
fdbny1p3
2 Aug 23
Results of Operations and Financial Condition
7:00am
8-K
EX-99.1
om3n9yy awzuvm
10 May 23
Results of Operations and Financial Condition
7:01am
DEFA14A
p4e82561z2cy
19 Apr 23
Additional proxy soliciting materials
4:12pm
8-K
EX-99.1
6ozemn7tvt38x9b
3 Nov 22
Key financial highlights and outlook
7:00am
8-K
EX-99.1
4rri 1svk
26 Jul 22
Key financial highlights and outlook
4:56pm
8-K
EX-99.1
0wvm3s wvghmd
3 May 22
Results of Operations and Financial Condition
7:01am
DEFA14A
t3k74qz 3eh6z
13 Apr 22
Additional proxy soliciting materials
9:04am